Drug Profile
Cyproterone acetate - Barr Laboratories
Alternative Names: CyPatLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Barr Laboratories
- Developer Barr Laboratories; Bristol-Myers Squibb
- Class Antiandrogens; Chlorinated steroids; Small molecules
- Mechanism of Action Testosterone congener inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hot flashes
Most Recent Events
- 19 May 2008 Discontinued - Phase-III for Hot flashes in USA (PO)
- 16 Nov 2007 Barr Pharmaceuticals completes Phase III trials for Hot flashes in patients with prostate cancer
- 09 May 2002 Company names or deal information has been updated in the overview section of the profile